Tackling PBMs’ worst abuses would help accomplish that objective without distorting the incentives for drugmakers to develop new medicines, as blunt instruments like price controls would. Democrats and Republicans alike should be able to get behind Sen. Wiener’s effort.
California State Senator Scott Wiener, D-San Francisco, recently introduced a bill aimed at reining in pharmacy benefit managers (PBMs), the middlemen largely responsible for the dysfunction plaguing our nation’s prescription drug market.
Wiener’s effort should attract the support of lawmakers on both the left and right. By cracking down on the activities of PBMs, they can deliver real savings for patients at the pharmacy counter.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.
California could lead the way on bipartisan prescription drug reform
Sally C. Pipes
Tackling PBMs’ worst abuses would help accomplish that objective without distorting the incentives for drugmakers to develop new medicines, as blunt instruments like price controls would. Democrats and Republicans alike should be able to get behind Sen. Wiener’s effort.
California State Senator Scott Wiener, D-San Francisco, recently introduced a bill aimed at reining in pharmacy benefit managers (PBMs), the middlemen largely responsible for the dysfunction plaguing our nation’s prescription drug market.
Wiener’s effort should attract the support of lawmakers on both the left and right. By cracking down on the activities of PBMs, they can deliver real savings for patients at the pharmacy counter.
Read the op-ed here:
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.